Table 3.
Factors Associated with Undernutrition Among People Living with HIV who were Enrolled in First-Line Antiretroviral Therapy at the Public Health Facility of Arba Minch Town, Southern Ethiopia, 2018
| Variable | Nutritional Status | COR (95% CI) | AOR (95% CI) | P-value | |
|---|---|---|---|---|---|
| Undernutrition | Normal | ||||
| Sex | |||||
| Female | 47 (25%) | 141 (75%) | 1 | 1 | 1 |
| Male | 32 (22.07%) | 113 (77.93%) | 1.18 (0.71, 1.97) | 1.42 (0.83, 2.42) | 0.203 |
| History of substance use | |||||
| Yes | 30 (20.27%) | 118 (79.73%) | 1.42 (0.85, 2.38) | 1.84 (1.09, 3.08) | 0.022** |
| No | 49 (26.49%) | 136 (73.51%) | 1 | 1 | |
| Disclosure status | |||||
| Disclosed | 26 (19.40%) | 108 (80.59%) | 1 | 1 | |
| Not disclosed | 53 (26.63%) | 146 (73.37%) | 0.66 (0.39, 1.13) | 1.37 (0.81, 2.31) | 0.25 |
| Duration on ART | |||||
| <12 months | 56 (26.29%) | 157 (73.71%) | 0.69 (0.40, 1.21) | 1.87 (1.06, 3.30) | 0.032** |
| ≥12 months | 23 (19.17%) | 97 (80.83%) | 1 | 1 | |
| WHO clinical stage | |||||
| Stage I or II | 71 (36.98%) | 121 (63.02%) | 1 | 1 | |
| Stage III or IV | 8 (5.67%) | 133 (94.33%) | 9.76 (4.51, 21.09) | 5.10 (2.90, 7.70) | 0.0001** |
| Cotrimoxazole preventive therapy | |||||
| Yes | 38 (19.00%) | 162 (81.00%) | 1 | 1 | |
| No | 41 (30.83%) | 92 (69.17%) | 0.53 (0.32, 0.88) | 2.09 (1.15, 3.82) | 0.016** |
| Isoniazid preventive therapy | |||||
| Yes | 55 (24.44%) | 170 (75.56%) | 1 | 1 | |
| No | 24 (22.22%) | 84 (77.78%) | 1.13 (0.66, 1.96) | 1.06 (0.56, 1.99) | 0.854 |
| Last CD4 count | |||||
| <350cells/mm3 | 32 (17.98) | 146 (82.02%) | 1.99 (1.19, 3.32) | 1.83 (1.09, 305) | 0.021** |
| ≥350 cells/mm3 | 47 (30.32%) | 108 (69.68) | 1 | 1 | |
| TB incident | |||||
| Yes | 18 (18.75%) | 78 (81.25%) | 1.53 (0.83, 2.71) | 1.89 (1.02, 3.53) | 0.045** |
| No | 61 (25.74%) | 176 (74.26%) | 1 | 1 | |
Note: **P-value ≤0.05 statistically significant. 1 = Reference category.
Abbreviation: CI, confidence interval.